Results 1 - 20 of 11,064 for All Library Resources
Sorted by:
Sorted by:
RelevanceOr hit Enter to replace sort method
- Relevance
- Date-newest
- Date-oldest
- Popularity
- Author
- Title
Refined by:
Database:
Oxford Journals Open Access Collection
Database:
Wiley-Blackwell Titles (Open access)
Database:
Wiley-Blackwell Titles (Open access)
| Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
|---|---|---|---|
| 1 |
Material Type: Article
|
|
Immune Checkpoint Inhibitor‐Associated MyocarditisThe oncologist (Dayton, Ohio), 2018-08, Vol.23 (8), p.879-886 [Peer Reviewed Journal]AlphaMed Press 2018 ;AlphaMed Press 2018. ;ISSN: 1083-7159 ;EISSN: 1549-490X ;DOI: 10.1634/theoncologist.2018-0130 ;PMID: 29802219Full text available |
| 2 |
Material Type: Article
|
|
Radiofrequency Ablation and Microwave Ablation in Liver Tumors: An UpdateThe oncologist (Dayton, Ohio), 2019-10, Vol.24 (10), p.e990-e1005 [Peer Reviewed Journal]AlphaMed Press 2019 ;AlphaMed Press 2019. ;ISSN: 1083-7159 ;EISSN: 1549-490X ;DOI: 10.1634/theoncologist.2018-0337 ;PMID: 31217342Full text available |
| 3 |
Material Type: Article
|
|
CheckMate 141: 1‐Year Update and Subgroup Analysis of Nivolumab as First‐Line Therapy in Patients with Recurrent/Metastatic Head and Neck CancerThe oncologist (Dayton, Ohio), 2018-09, Vol.23 (9), p.1079-1082 [Peer Reviewed Journal]AlphaMed Press 2018 ;AlphaMed Press 2018. ;ISSN: 1083-7159 ;EISSN: 1549-490X ;DOI: 10.1634/theoncologist.2017-0674 ;PMID: 29866947Full text available |
| 4 |
Material Type: Article
|
|
FDA Approval Summary: Tocilizumab for Treatment of Chimeric Antigen Receptor T Cell‐Induced Severe or Life‐Threatening Cytokine Release SyndromeThe oncologist (Dayton, Ohio), 2018-08, Vol.23 (8), p.943-947 [Peer Reviewed Journal]Published 2018. This article is a U.S. Government work and is in the public domain in the USA ;Published 2018. This article is a U.S. Government work and is in the public domain in the USA. ;ISSN: 1083-7159 ;EISSN: 1549-490X ;DOI: 10.1634/theoncologist.2018-0028 ;PMID: 29622697Full text available |
| 5 |
Material Type: Article
|
|
Inflammatory Arthritis: A Newly Recognized Adverse Event of Immune Checkpoint BlockadeThe oncologist (Dayton, Ohio), 2017-06, Vol.22 (6), p.627-630 [Peer Reviewed Journal]2017 AlphaMed Press ;ISSN: 1083-7159 ;EISSN: 1549-490X ;DOI: 10.1634/theoncologist.2016-0390 ;PMID: 28576858Full text available |
| 6 |
Material Type: Article
|
|
BRAF V600E/RAS Mutations and Lynch Syndrome in Patients With MSI-H/dMMR Metastatic Colorectal Cancer Treated With Immune Checkpoint InhibitorsThe oncologist (Dayton, Ohio), 2023-09, Vol.28 (9), p.771-779 [Peer Reviewed Journal]The Author(s) 2023. Published by Oxford University Press. 2023 ;The Author(s) 2023. Published by Oxford University Press. ;ISSN: 1083-7159 ;EISSN: 1549-490X ;DOI: 10.1093/oncolo/oyad082 ;PMID: 37023721Full text available |
| 7 |
Material Type: Article
|
|
Early and Late Recurrence of Hepatitis B Virus‐Associated Hepatocellular CarcinomaThe oncologist (Dayton, Ohio), 2020-10, Vol.25 (10), p.e1541-e1551 [Peer Reviewed Journal]AlphaMed Press 2020 ;AlphaMed Press 2020. ;ISSN: 1083-7159 ;EISSN: 1549-490X ;DOI: 10.1634/theoncologist.2019-0944 ;PMID: 32472951Full text available |
| 8 |
Material Type: Article
|
|
Larotrectinib Treatment for Patients With TRK Fusion-Positive Salivary Gland CancersThe oncologist (Dayton, Ohio), 2022-05 [Peer Reviewed Journal]The Author(s) 2022. Published by Oxford University Press. ;ISSN: 1083-7159 ;EISSN: 1549-490X ;DOI: 10.1093/oncolo/oyac080 ;PMID: 35536733Full text available |
| 9 |
Material Type: Article
|
|
Ipilimumab and Gemcitabine for Advanced Pancreatic Cancer: A Phase Ib StudyThe oncologist (Dayton, Ohio), 2020-05, Vol.25 (5), p.e808-e815 [Peer Reviewed Journal]AlphaMed Press 2019 ;AlphaMed Press 2019. ;ISSN: 1083-7159 ;EISSN: 1549-490X ;DOI: 10.1634/theoncologist.2019-0473 ;PMID: 31740568Full text available |
| 10 |
Material Type: Article
|
|
Anti‐Hu‐Associated Autoimmune Limbic Encephalitis in a Patient with PD‐1 Inhibitor‐Responsive Myxoid ChondrosarcomaThe oncologist (Dayton, Ohio), 2018-01, Vol.23 (1), p.118-120 [Peer Reviewed Journal]AlphaMed Press 2017 ;AlphaMed Press 2017. ;ISSN: 1083-7159 ;EISSN: 1549-490X ;DOI: 10.1634/theoncologist.2017-0344 ;PMID: 29158368Full text available |
| 11 |
Material Type: Article
|
|
Longitudinal trajectories of a claims-based frailty measure during adjuvant chemotherapy in women with stage I-III breast cancerThe oncologist (Dayton, Ohio), 2024-05 [Peer Reviewed Journal]The Author(s) 2024. Published by Oxford University Press. ;EISSN: 1549-490X ;DOI: 10.1093/oncolo/oyae092 ;PMID: 38716777Full text available |
| 12 |
Material Type: Article
|
|
Clinical actionability of BRCA2 alterations in uterine leiomyosarcoma: a molecular tumor board case report and a cBioPortal comprehensive analysisThe oncologist (Dayton, Ohio), 2024-05 [Peer Reviewed Journal]The Author(s) 2024. Published by Oxford University Press. ;EISSN: 1549-490X ;DOI: 10.1093/oncolo/oyae082 ;PMID: 38716772Full text available |
| 13 |
Material Type: Article
|
|
From ownership to custodianship of tumor biopsy tissue in genomic testing: a mixed methods study of patient viewsThe oncologist (Dayton, Ohio), 2024-05 [Peer Reviewed Journal]The Author(s) 2024. Published by Oxford University Press. ;EISSN: 1549-490X ;DOI: 10.1093/oncolo/oyae074 ;PMID: 38713191Full text available |
| 14 |
Material Type: Article
|
|
Serious Cutaneous Toxicities with Immune Checkpoint Inhibitors in the U.S. Food and Drug Administration Adverse Event Reporting SystemThe oncologist (Dayton, Ohio), 2019-11, Vol.24 (11), p.e1228-e1231 [Peer Reviewed Journal]AlphaMed Press 2019 ;AlphaMed Press 2019. ;ISSN: 1083-7159 ;EISSN: 1549-490X ;DOI: 10.1634/theoncologist.2019-0250 ;PMID: 31387950Full text available |
| 15 |
Material Type: Article
|
|
Rational treatment options for T1/2N0M0 squamous cell carcinoma of the anal canal: a population-based study combined with external validationThe oncologist (Dayton, Ohio), 2024-04 [Peer Reviewed Journal]The Author(s) 2024. Published by Oxford University Press. ;EISSN: 1549-490X ;DOI: 10.1093/oncolo/oyae068 ;PMID: 38688457Full text available |
| 16 |
Material Type: Article
|
|
Association of opioid use with survival in patients with cancer treated with immune checkpoint inhibitors: it is time for evidence-based behaviorsThe oncologist (Dayton, Ohio), 2024-04 [Peer Reviewed Journal]The Author(s) 2024. Published by Oxford University Press. ;EISSN: 1549-490X ;DOI: 10.1093/oncolo/oyae081 ;PMID: 38688456Full text available |
| 17 |
Material Type: Article
|
|
Comparing Drug Shortages Experienced by Institutions With National MetricsThe oncologist (Dayton, Ohio), 2024-02 [Peer Reviewed Journal]The Author(s) 2024. Published by Oxford University Press. ;EISSN: 1549-490X ;DOI: 10.1093/oncolo/oyad350 ;PMID: 38366856Full text available |
| 18 |
Material Type: Article
|
|
Perception of Polish patients with cancer of the ethical and legal issues related to biobank researchThe oncologist (Dayton, Ohio), 2024-04 [Peer Reviewed Journal]The Author(s) 2024. Published by Oxford University Press. ;EISSN: 1549-490X ;DOI: 10.1093/oncolo/oyae078 ;PMID: 38666716Full text available |
| 19 |
Material Type: Article
|
|
Impact of neoadjuvant pembrolizumab adherence on pathologic complete response in triple-negative breast cancer: a real-world analysisThe oncologist (Dayton, Ohio), 2024-04 [Peer Reviewed Journal]The Author(s) 2024. Published by Oxford University Press. ;EISSN: 1549-490X ;DOI: 10.1093/oncolo/oyae064 ;PMID: 38656345Full text available |
| 20 |
Material Type: Article
|
|
Automated Quantitative CD8+ Tumor-Infiltrating Lymphocytes and Tumor Mutation Burden as Independent Biomarkers in Melanoma Patients Receiving Front-Line Anti-PD-1 ImmunotherapyThe oncologist (Dayton, Ohio), 2024-04 [Peer Reviewed Journal]The Author(s) 2024. Published by Oxford University Press. ;EISSN: 1549-490X ;DOI: 10.1093/oncolo/oyae054 ;PMID: 38655867Full text available |
Results 1 - 20 of 11,064 for All Library Resources
Sorted by:
Sorted by:
RelevanceOr hit Enter to replace sort method
- Relevance
- Date-newest
- Date-oldest
- Popularity
- Author
- Title
Personalize your results
Refine Search Results
Expand My Results
Refine My Results
Creation Date
- Before 2000 (166)
- 2000 To 2005 (925)
- 2006 To 2011 (1,498)
- 2012 To 2018 (3,420)
- After 2018 (5,056)
-
More options
New Records
Subject
- Life Sciences & Biomedicine (11,002)
- Humans (6,431)
- Oncology (4,998)
- Female (2,837)
- Male (2,387)
- Middle Aged (1,875)
- Adult (1,847)
- Public, Environmental & Occupational Health (1,763)
- Cell Biology (1,596)
- Cell & Tissue Engineering (1,596)
- Stem Cells (1,329)
- Aged (1,312)
- Original (1,179)
- Surgery (1,025)
- Cancer (918)
- Animals (909)
- Cancer Research (844)
- Care And Treatment (742)
- Analysis (700)
-
More options
Databases
- Open Access: Oxford University Press Open Journals (11,064)
- Open Access: Wiley-Blackwell Open Access Journals (11,064)
- PubMed Central (10,907)
- DOAJ Directory of Open Access Journals (10,825)
- MEDLINE (6,814)
- Geneva Foundation Free Medical Journals at publisher websites (6,790)
- ProQuest Central (5,326)
- HighWire Press (Free Journals) (5,037)
- ROAD: Directory of Open Access Scholarly Resources (4,279)
- Journals@Ovid Open Access Journal Collection Rolling (2,221)
- SWEPUB Freely available online (259)
- Coronavirus Research Database (131)
- Hyper Article en Ligne (HAL) (Open Access) (105)
- IngentaConnect Open Access (41)
- NORA - Norwegian Open Research Archives (33)
- AgEcon (21)
- Spiral (17)
- Open Access: Freely Accessible Journals by multiple vendors (13)
- Recercat (4)
- Ebook Central - Academic Complete (1)
-
More options
Language
- Japanese (2,995)
- Norwegian (18)
- Chinese (1)
- German (1)
-
More options
Journal Title
- Bjs Open (835)
- Evolution Letters (345)
- Fems Microbiology Letters (46)
- Fems Microbiology Reviews (29)
- Jbmr Plus (623)
- Journal Of Occupational Health (1,763)
- Sexual Medicine (650)
- Stem Cells Translational Medicine (1,579)
- The Oncologist (4,970)
- Transactions Of The London Mathematical Society (48)
-
More options
|
||||
 |
INSPIRE LIBRARY - TON DUC THANG UNIVERSITY |  |
(84-028) 37 755 057 | Feedback |
| 19 Nguyen Huu Tho St. Dist.7, HCM |  |
thuvien@tdtu.edu.vn | ||